Eskulapg.Czarneckisp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2005-12-20
Share capital
85,000.00 PLN
Registered address
Kraków, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 525 days for 2020).

  • 2024not filed
  • 202326/03/2024
  • 202203/07/2023
  • 202127/03/2023
  • 202024/03/2023
  • 201924/07/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.

Industry · Manufacture of basic pharmaceutical products15 / 69
Top 22%
Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations136 / 330
Top 41%
Sector · Manufacturing14,136 / 33,744
Top 42%
Voivodeship · Małopolskie10,266 / 46,035
Top 22%
Country · Poland113,926 / 495,860
Top 23%

Results vs industry

Revenue
This companyUSD 1.10mMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD -128.56kMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 1.21mMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 2.98mMedianUSD 118.27kAverageUSD 1.54m

Industry

Trademarks

Eskulapg.Czarnecki currently holds no active trademarks with the Polish Patent Office. 7 marks have expired or were not registered. The first mark was filed in 2010.

MarkNumberClassesStatusProtected until
Piekielna moc NEVER ENOUGH ENERGIAZ.39481032Expired –
NEVER ENOUGH(word)Z.39481132Expired –
grupa APTEKI ESKULAPZ.39121435, 41, 44Refused –
grupa APTEKI ESKULAPZ.39121735, 41, 44Refused –
FLEBROMAX(word)Z.3741275Expired –
MarkProtected until
Piekielna moc NEVER ENOUGH ENERGIA–
NEVER ENOUGH(word)–
grupa APTEKI ESKULAP–
grupa APTEKI ESKULAP–
FLEBROMAX(word)–

Authorized Representatives

Marcin Łukasz Dębiński – Attorney-in-fact (sole)
Michał Jacek Kozioł – President of the Management Board

Manner of representation

Authorized to submit declarations of will and sign on behalf of the company are: in the case of a one-person management board, the company is represented by the President of the Management Board; in the case of a multi-member management board, joint action by two members of the management board or by a member of the management board jointly with a commercial proxy is required.

Ownership

OwnerSharesShare valueStake
Marcin Łukasz Dębińskiage 45
170$22,960.56100%

Beneficial owners

Person

Subsidiaries

NameStake
Apteka Medicussp. z o.o.
99.8788%

Bank accounts

Was a VAT taxpayer from 2006-06-19 to 2026-04-29.

Reason for removal: Art. 96 ust. 9 pkt 3 (data provided in the VAT-R registration form is false)

Debt

1 closed proceeding recorded in KRZ history.

Registration dateProceeding typeStatus
May 30, 2026
Discontinued enforcement proceedings
Closed

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A.
Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A.
Natur DayS.A.
Biotriosp. z o.o.
F1 PharmaS.A.
Nature's Voicesp. z o.o.
Pexon Polandsp. z o.o.
Bioresearch PharmaS.A.
Zakład Farmaceutyczny Amarasp. j.
Grupa FinepharmS.A.

Change history

DateEvent
2026-04-24Address change
2019-03-18Address change
2015-10-09Address change
2015-04-27Address change
2015-04-27PKD change

FAQ

Last updated: 2026-10-07